PENNISI, MARIA STELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.330
AS - Asia 566
EU - Europa 553
SA - Sud America 187
AF - Africa 163
OC - Oceania 1
Totale 2.800
Nazione #
US - Stati Uniti d'America 1.298
IT - Italia 253
SG - Singapore 242
BR - Brasile 170
CN - Cina 149
CI - Costa d'Avorio 113
IE - Irlanda 95
VN - Vietnam 55
DE - Germania 52
IN - India 47
SN - Senegal 35
RU - Federazione Russa 27
GB - Regno Unito 25
FI - Finlandia 22
CA - Canada 20
JP - Giappone 13
BE - Belgio 12
SE - Svezia 10
MX - Messico 9
PL - Polonia 9
AR - Argentina 8
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
ES - Italia 7
KR - Corea 7
TR - Turchia 7
BD - Bangladesh 6
HK - Hong Kong 6
IQ - Iraq 6
UA - Ucraina 6
ZA - Sudafrica 6
FR - Francia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
NO - Norvegia 4
EC - Ecuador 3
ID - Indonesia 3
IL - Israele 3
MA - Marocco 3
NL - Olanda 3
CO - Colombia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
NG - Nigeria 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
GD - Grenada 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 2.800
Città #
Santa Clara 215
Dallas 212
Chandler 194
Singapore 148
Abidjan 113
Chicago 101
Dublin 95
Ashburn 63
Catania 62
Beijing 49
Los Angeles 38
Civitanova Marche 34
Dakar 34
Kochi 32
Boardman 31
Cambridge 27
Lawrence 25
Andover 24
Grafing 23
Dong Ket 22
New York 20
Wilmington 17
Munich 16
São Paulo 15
The Dalles 15
Des Moines 14
Columbus 13
Tokyo 13
Brussels 12
Council Bluffs 12
Turku 12
Hefei 11
Palermo 11
Hanoi 10
Ho Chi Minh City 10
Montreal 10
Nanjing 10
Belo Horizonte 9
Buffalo 9
Santa Venerina 9
Brno 8
Helsinki 8
Bari 7
Seoul 7
Houston 6
Johannesburg 6
Milan 6
Pune 6
Seattle 6
Toronto 6
Aci Catena 5
Chennai 5
Rio de Janeiro 5
Warsaw 5
Bremen 4
Edinburgh 4
Falls Church 4
Frankfurt am Main 4
Giardini-Naxos 4
Hong Kong 4
Jiaxing 4
London 4
Saint Petersburg 4
Tashkent 4
Tremestieri Etneo 4
Catanzaro 3
Fantina 3
Guarulhos 3
Hanover 3
Jakarta 3
Jinan 3
Manaus 3
Manchester 3
Messina 3
Orem 3
Oslo 3
Poplar 3
Querétaro 3
Quảng Ngãi 3
San Giovanni la Punta 3
Volta Redonda 3
Woodbridge 3
Abuja 2
Baghdad 2
Belém 2
Blumenau 2
Boston 2
Brasília 2
Buenos Aires 2
Cabo Frio 2
Campo Grande 2
Casablanca 2
Comiso 2
Cáceres 2
Dubai 2
Duque de Caxias 2
Fairfield 2
Haiphong 2
Istanbul 2
Jackson 2
Totale 2.007
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 178
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 133
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 131
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 128
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 121
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 117
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 117
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 116
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 116
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 111
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 110
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 109
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 107
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 104
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 104
New insights in thyroid cancer and p53 family proteins 98
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 95
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 89
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 89
Opportunities and challenges of liquid biopsy in thyroid cancer 87
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 85
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 84
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 78
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 76
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 75
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 75
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 72
The Role of New Technologies in Myeloproliferative Neoplasms 66
Totale 2.871
Categoria #
all - tutte 10.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 23 5 2 2 26 2 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025959 13 154 38 87 187 132 97 30 31 46 113 31
2025/2026671 97 94 230 127 123 0 0 0 0 0 0 0
Totale 2.871